Immobilization of heparin on decellularized kidney scaffold to construct microenvironment for antithrombosis and inducing reendothelialization

Sci China Life Sci. 2018 Oct;61(10):1168-1177. doi: 10.1007/s11427-018-9387-4. Epub 2018 Sep 27.

Abstract

In recent years, rapid development of tissue engineering technology provides possibilities for the construction of artificial tissues or organs. In construction of engineered kidneys, researchers used native decellularized extracellular matrix (ECM) as the scaffolds to recellularization. However, thrombosis has been a great issue that hinders the progress of transplantation in vivo. In this study, heparin was immobilized to the collagen part of decellularized scaffold with collagen-binding peptide (CBP). Through the anticoagulant and endothelial cell reperfusion experiments, it can be demonstrated that the heparinized scaffolds absorbed less platelets and red blood cells which can effectively reduce the formation of thrombosis. Moreover, it is conducive to long-term adhesion of endothelial cells which is important for the formation of subsequent vascularization. Taken together, our results reveal that the whole kidney can be modified by CBP-heparin composite to reduce the thrombosis and provide the better conditions for neovascularization.

Keywords: antithrombosis; decellularization; kidney; reendothelialization; scaffold.

MeSH terms

  • Animals
  • Anticoagulants / metabolism
  • Anticoagulants / pharmacology
  • Cells, Cultured
  • Cellular Microenvironment*
  • Endothelial Cells / drug effects
  • Endothelial Cells / metabolism*
  • Extracellular Matrix / metabolism
  • Heparin / metabolism*
  • Heparin / pharmacology
  • Humans
  • Kidney / cytology
  • Kidney / metabolism*
  • Kidney / ultrastructure
  • Peptide Fragments / metabolism
  • Peptide Fragments / pharmacology
  • Platelet Adhesiveness
  • Rats, Sprague-Dawley
  • Sialoglycoproteins / metabolism
  • Sialoglycoproteins / pharmacology
  • Thrombosis / metabolism*
  • Thrombosis / prevention & control
  • Tissue Engineering / methods
  • Tissue Scaffolds*

Substances

  • Anticoagulants
  • Peptide Fragments
  • Sialoglycoproteins
  • bone sialoprotein (35-62), human
  • Heparin